Aethlon Medical Has Received A Notice Of Allowance For A U.S. Patent Titled "DEVICES AND METHODS FOR TREATING A VIRAL INFECTION AND SYMPTOMS THEREOF".
https://patentcenter.uspto.gov/applications/18700571/ifw/docs
Stocks · News reference
Patients In Aethlon Medical's Second Cohort Of Its Australian Oncology Feasibility Study Demonstrated Biological Changes
Second cohort findings consistent with previously reported observations; independent statistical analysis planned following completion of all three patient cohorts
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — AETHLON MEDICAL INC (AEMD)
Filed: 2026-08-31 AccNo: 0001683168-26-006815 Size: 188 KB Item 8.01: Other Events
Why Elastic Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
Elastic NV (ESTC) stock rose 21.8% in pre-market trading after reporting strong Q1 results and raising FY27 guidance. Other top gainers include WHLR, QNRX, AEMD, NA, SOLS, HYNE, GAP, AFRM, and ARKR. Top losers are BTAI, LGPS, FGL, HCWC, and KTCC.
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Picard Medical (AMEX:PMI) shares moved upwards by 34.6% to $4.32 during Monday's pre-market session. The company's market cap stands at $6.5 million. As per the press release, Q2 earnings came out 3